Unlock instant, AI-driven research and patent intelligence for your innovation.

Hepatitis B gene plant expression carrier plasmid, hepatitis B transgene cell line and its commercial production use

A plant cell and cell line technology, applied in the field of hepatitis B vaccine preparation, can solve the problems of not meeting social needs and low expression level

Inactive Publication Date: 2004-09-29
NINGBO RONGAN BIOLOGICAL PHARMA
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the existing production capacity in my country is limited by the expression system (CHO seedlings and yeast seedlings) and the expression level is low, which is far from meeting the needs of the society (the market share of 30 million tubes per year is vacant), and it is urgent to find a new expression system.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Construction of Plant Cell Expression Vector of Hepatitis B Virus Surface Antigen Gene

[0041] 1. Extraction of chromosomal DNA from C28 cells

[0042] Take more than 80% of the adherent C28 cells (containing the HBV surface antigen S gene), wash the cells with PBS buffer, digest with 25% trypsin, resuspend the cells in TBS buffer, and harvest the cells by centrifugation. Resuspend the cells with TE (pH8.0) to make the concentration 5×107 / ml, take 1ml and add 10ml extraction buffer (10mmol / L Tris.Cl (pH8.0), 0.1mol / L EDTA (pH8.0) , 20ug / ml Trypsin, 0.5SDS), 37°C for 1 hour. Add proteinase K to a final concentration of 100ug / ml, and keep at 50°C for 3 hours. Cool to room temperature, add an equal volume of equilibrated phenol for extraction, and collect the aqueous phase by centrifugation. Add twice the volume of absolute ethanol, after mixing, centrifuge to discard the supernatant, wash the DNA precipitate with 75% ethanol, centrifuge to discard the supernatant, dry...

Embodiment 2

[0056] Expression vector transformed into Agrobacterium

[0057] 1. Preparation of Agrobacterium LBA4404 Competent Cells

[0058] Inoculate a single colony of Agrobacterium LBA4404 in 5ml YEP liquid medium, and culture overnight at 28°C and 220rpm. Take 2ml of the overnight culture and transfer it into 50ml of YEP liquid medium, culture at 28°C 220rpm until the OD600 is about 0.5, cool in ice for 30 minutes, centrifuge at 5000rpm at 4°C for 5 minutes, and discard the supernatant. Add 20ml of 50mmol / L CaCl2 to resuspend the bacteria, centrifuge at 5000rpm at 4°C for 5 minutes, and discard the supernatant. Add 2ml of 50mmol / L CaCl2 to resuspend the bacteria, aliquot 200ul per tube, and store at -80°C.

[0059] 2. Transformation of Agrobacterium

[0060] Take 20ng of the purified plasmid pBIBS, add it to 200ul competent Agrobacterium, mix well, ice bath for 5 minutes, transfer to liquid nitrogen to freeze for 8 minutes, and quickly incubate at 37°C for 5 minutes. Add 800ul YE...

Embodiment 3

[0064] Plant cell resistance sensitive pre-experiment

[0065] Ginseng callus cells were cultured in the following four mediums, and 1.5 g of ginseng callus solid culture cells were added to every 25 ml of medium.

[0066] 1. Ampicillin-resistant group: 60ul, 120ul, 180ul, 240ul, 360ul, 500ul of 50mg / ml ampicillin were added to 25ml 67V solid medium.

[0067] 2. Kanamycin-resistant group: 5ul, 10ul, 25ul, 50ul, 75ul, 100ul, 150ul of 50mg / ml kanamycin were added to 25ml 67V solid medium.

[0068] 3. G418 resistance group: 50 mg / ml G4185ul, 10ul, 25ul, 50ul, 75ul, 100ul, 150ul were added to 25ml 67V solid medium.

[0069] 4. Control group: 25ml 67V solid medium.

[0070] Comparing the growth situation within one month: there is no significant difference between the different resistance concentrations of the 4 groups and the 1 group, and the ginseng cells grow from 1.5g to 6~7g, indicating that the ginseng cells can grow normally in the presence of high-concentration ampicillin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to transgenic plant cell line and plant cell expression system to express hepatitis B surface antigen. The present invention also relates to the method of preparing the said cell line or expression system, and the application of the cell line or expression system in preparing hepatitis B surface antigen protein. The cell line or expression system the present invention also discloses may be used in preparing vaccine for hepatitis B virus.

Description

technical field [0001] The invention relates to the field of plant transgenic technology. More specifically, the present invention relates to constructing a transgenic ginseng callus cell line expressing hepatitis B virus surface antigen, obtaining the hepatitis B virus surface antigen, and using it for the preparation of hepatitis B vaccine. Background technique [0002] Hepatitis B is one of the most widespread and serious infectious diseases in China. At present, there are about 350 million hepatitis B carriers in the world, and there are more than 120 million hepatitis B carriers in my country, and there are 30 million chronic hepatitis B patients in the society. There are more than 2 million cases of acute hepatitis every year. About 350,000 people died of liver disease, half of which were primary liver cancer. Seriously affected the social stability of our country and the development of the national economy. [0003] Protection against HBV infection will still depend...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/51C12N15/82
CPCC12N15/8257C12N15/8258
Inventor 盛军刘丹刘晓宇郭桥于海鹏李鹃回悦君王志武张雪梅
Owner NINGBO RONGAN BIOLOGICAL PHARMA